Peer-Led Drug Harm Reduction Programme
In plain English
The notice doesn't say
The notice as published
The service will be a community-based, harm reduction service that will complement existing drug and alcohol treatment, street outreach, pharmacy and public health provision by providing low-threshold, peer-led engagement and harm reduction support and advice. This will include provision of needles and safer injecting equipment, training and provision of naloxone, safer drug use information and brief intervention, blood-borne virus prevention information and signposting to further drug and alcohol, physical, mental health and housing support. The service, for adult Camden residents will primarily be focused on people experiencing homelessness, those living in hostels or supported accommodation, those not engaged in structured treatment services and women, particularly those facing multiple disadvantage. Having considered the nature of the service, the identified needs of the borough, and the provider's proven expertise and track record in delivering specialist peer-led interventions, the Council has applied the Most Suitable Provider process under the PSR. This approach enables the Council to secure a high-quality, value-for-money service that aligns with local priorities, supports improved health outcomes for vulnerable residents, and contributes to the wider strategic objectives of reducing drug-related harm and health inequalities. This notice is an intention to award a contract under the most suitable provider process. This is a new Service and Hepatitus C is a new provider for Camden. The Service wil commence on 1 November 2026 for 12 months at a total value of £150,000. Additional information: Award of a contract without prior publication of a call for competition, as selected in the preliminary questions.